nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromodiphenhydramine—Toremifene—breast cancer	0.339	0.614	CrCtD
Bromodiphenhydramine—Tamoxifen—breast cancer	0.213	0.386	CrCtD
Bromodiphenhydramine—SLC47A1—Mitoxantrone—breast cancer	0.113	0.928	CbGbCtD
Bromodiphenhydramine—Bedaquiline—Toremifene—breast cancer	0.0549	0.176	CrCrCtD
Bromodiphenhydramine—Bedaquiline—Tamoxifen—breast cancer	0.0345	0.11	CrCrCtD
Bromodiphenhydramine—Cloperastine—Raloxifene—breast cancer	0.0261	0.0835	CrCrCtD
Bromodiphenhydramine—Tamoxifen—Toremifene—breast cancer	0.0228	0.0729	CrCrCtD
Bromodiphenhydramine—Toremifene—Tamoxifen—breast cancer	0.0208	0.0667	CrCrCtD
Bromodiphenhydramine—Doxylamine—Toremifene—breast cancer	0.0191	0.061	CrCrCtD
Bromodiphenhydramine—Clofedanol—Toremifene—breast cancer	0.0131	0.0419	CrCrCtD
Bromodiphenhydramine—Cyclobenzaprine—Tamoxifen—breast cancer	0.013	0.0417	CrCrCtD
Bromodiphenhydramine—Orphenadrine—Toremifene—breast cancer	0.0127	0.0405	CrCrCtD
Bromodiphenhydramine—Benzphetamine—Toremifene—breast cancer	0.0127	0.0405	CrCrCtD
Bromodiphenhydramine—Doxylamine—Tamoxifen—breast cancer	0.012	0.0383	CrCrCtD
Bromodiphenhydramine—Diphenhydramine—Toremifene—breast cancer	0.0112	0.036	CrCrCtD
Bromodiphenhydramine—Tripelennamine—Tamoxifen—breast cancer	0.0108	0.0346	CrCrCtD
Bromodiphenhydramine—Dimetacrine—Tamoxifen—breast cancer	0.0101	0.0324	CrCrCtD
Bromodiphenhydramine—SLC22A6—Methotrexate—breast cancer	0.0087	0.0715	CbGbCtD
Bromodiphenhydramine—Clofedanol—Tamoxifen—breast cancer	0.00822	0.0263	CrCrCtD
Bromodiphenhydramine—Benzphetamine—Tamoxifen—breast cancer	0.00795	0.0254	CrCrCtD
Bromodiphenhydramine—Orphenadrine—Tamoxifen—breast cancer	0.00795	0.0254	CrCrCtD
Bromodiphenhydramine—Promazine—Tamoxifen—breast cancer	0.00759	0.0243	CrCrCtD
Bromodiphenhydramine—Diphenhydramine—Tamoxifen—breast cancer	0.00706	0.0226	CrCrCtD
Bromodiphenhydramine—SLC47A1—nipple—breast cancer	0.00033	0.127	CbGeAlD
Bromodiphenhydramine—Tamoxifen—ESRRA—breast cancer	0.000225	0.101	CrCbGaD
Bromodiphenhydramine—SLC47A1—endometrium—breast cancer	0.000199	0.0768	CbGeAlD
Bromodiphenhydramine—SLC47A1—uterus—breast cancer	0.000183	0.0708	CbGeAlD
Bromodiphenhydramine—Dimetacrine—ACHE—breast cancer	0.000181	0.0811	CrCbGaD
Bromodiphenhydramine—SLC47A1—pituitary gland—breast cancer	0.00018	0.0695	CbGeAlD
Bromodiphenhydramine—SLC47A1—adipose tissue—breast cancer	0.000179	0.0692	CbGeAlD
Bromodiphenhydramine—Tamoxifen—SULT1A1—breast cancer	0.000171	0.0765	CrCbGaD
Bromodiphenhydramine—SLC47A1—female reproductive system—breast cancer	0.000165	0.0636	CbGeAlD
Bromodiphenhydramine—HRH1—nipple—breast cancer	0.000162	0.0626	CbGeAlD
Bromodiphenhydramine—SLC47A1—adrenal gland—breast cancer	0.000161	0.0621	CbGeAlD
Bromodiphenhydramine—SLC47A1—female gonad—breast cancer	0.00015	0.0579	CbGeAlD
Bromodiphenhydramine—SLC47A1—endocrine gland—breast cancer	0.000139	0.0538	CbGeAlD
Bromodiphenhydramine—HRH1—epithelium—breast cancer	0.000109	0.0421	CbGeAlD
Bromodiphenhydramine—Cyclopentolate—BCHE—breast cancer	0.000104	0.0467	CrCbGaD
Bromodiphenhydramine—HRH1—endometrium—breast cancer	9.78e-05	0.0378	CbGeAlD
Bromodiphenhydramine—SLC47A1—lymph node—breast cancer	9.64e-05	0.0372	CbGeAlD
Bromodiphenhydramine—Bedaquiline—CYP3A4—breast cancer	9.26e-05	0.0414	CrCbGaD
Bromodiphenhydramine—HRH1—adipose tissue—breast cancer	8.82e-05	0.034	CbGeAlD
Bromodiphenhydramine—HRH1—female reproductive system—breast cancer	8.11e-05	0.0313	CbGeAlD
Bromodiphenhydramine—HRH1—adrenal gland—breast cancer	7.91e-05	0.0305	CbGeAlD
Bromodiphenhydramine—Toremifene—ESR1—breast cancer	7.41e-05	0.0332	CrCbGaD
Bromodiphenhydramine—HRH1—female gonad—breast cancer	7.38e-05	0.0285	CbGeAlD
Bromodiphenhydramine—HRH1—endocrine gland—breast cancer	6.86e-05	0.0265	CbGeAlD
Bromodiphenhydramine—Fenoprofen—PTGS1—breast cancer	6.11e-05	0.0273	CrCbGaD
Bromodiphenhydramine—Toremifene—CYP1A1—breast cancer	5.93e-05	0.0265	CrCbGaD
Bromodiphenhydramine—Orphenadrine—SCN10A—breast cancer	5.57e-05	0.0249	CrCbGaD
Bromodiphenhydramine—Hydroxyzine—CYP2D6—breast cancer	5.46e-05	0.0244	CrCbGaD
Bromodiphenhydramine—Mepyramine—CYP2D6—breast cancer	4.96e-05	0.0222	CrCbGaD
Bromodiphenhydramine—Tamoxifen—ESR2—breast cancer	4.81e-05	0.0215	CrCbGaD
Bromodiphenhydramine—HRH1—lymph node—breast cancer	4.74e-05	0.0183	CbGeAlD
Bromodiphenhydramine—Tripelennamine—CYP2D6—breast cancer	4.59e-05	0.0205	CrCbGaD
Bromodiphenhydramine—Tamoxifen—CYP1B1—breast cancer	4.38e-05	0.0196	CrCbGaD
Bromodiphenhydramine—Cyclobenzaprine—CYP2D6—breast cancer	3.81e-05	0.0171	CrCbGaD
Bromodiphenhydramine—Toremifene—CYP3A4—breast cancer	3.78e-05	0.0169	CrCbGaD
Bromodiphenhydramine—Tolterodine—CYP2D6—breast cancer	3.65e-05	0.0164	CrCbGaD
Bromodiphenhydramine—Fenoprofen—PTGS2—breast cancer	3.49e-05	0.0156	CrCbGaD
Bromodiphenhydramine—Fluoxetine—CYP2D6—breast cancer	3.49e-05	0.0156	CrCbGaD
Bromodiphenhydramine—Cyclobenzaprine—CYP3A4—breast cancer	3.27e-05	0.0146	CrCbGaD
Bromodiphenhydramine—Tamoxifen—CYP19A1—breast cancer	3.22e-05	0.0144	CrCbGaD
Bromodiphenhydramine—Toremifene—ABCB1—breast cancer	3.15e-05	0.0141	CrCbGaD
Bromodiphenhydramine—Carbinoxamine—CYP2D6—breast cancer	3.14e-05	0.014	CrCbGaD
Bromodiphenhydramine—Tolterodine—CYP3A4—breast cancer	3.14e-05	0.014	CrCbGaD
Bromodiphenhydramine—Fenoprofen—ALB—breast cancer	3.11e-05	0.0139	CrCbGaD
Bromodiphenhydramine—Tamoxifen—ABCG2—breast cancer	3.02e-05	0.0135	CrCbGaD
Bromodiphenhydramine—Fluoxetine—CYP3A4—breast cancer	2.99e-05	0.0134	CrCbGaD
Bromodiphenhydramine—Tamoxifen—ESR1—breast cancer	2.96e-05	0.0132	CrCbGaD
Bromodiphenhydramine—Brompheniramine—CYP2D6—breast cancer	2.72e-05	0.0122	CrCbGaD
Bromodiphenhydramine—Carbinoxamine—CYP3A4—breast cancer	2.69e-05	0.012	CrCbGaD
Bromodiphenhydramine—Chlorphenamine—CYP2D6—breast cancer	2.67e-05	0.0119	CrCbGaD
Bromodiphenhydramine—Diphenhydramine—PTGS1—breast cancer	2.66e-05	0.0119	CrCbGaD
Bromodiphenhydramine—Fluoxetine—ALB—breast cancer	2.61e-05	0.0117	CrCbGaD
Bromodiphenhydramine—Fluoxetine—ABCB1—breast cancer	2.49e-05	0.0111	CrCbGaD
Bromodiphenhydramine—Tamoxifen—CYP1A1—breast cancer	2.37e-05	0.0106	CrCbGaD
Bromodiphenhydramine—Brompheniramine—CYP3A4—breast cancer	2.33e-05	0.0104	CrCbGaD
Bromodiphenhydramine—Chlorphenamine—CYP3A4—breast cancer	2.29e-05	0.0102	CrCbGaD
Bromodiphenhydramine—Atomoxetine—CYP2D6—breast cancer	2.24e-05	0.01	CrCbGaD
Bromodiphenhydramine—Benzphetamine—CYP3A4—breast cancer	1.94e-05	0.00867	CrCbGaD
Bromodiphenhydramine—Atomoxetine—CYP3A4—breast cancer	1.92e-05	0.0086	CrCbGaD
Bromodiphenhydramine—Diphenhydramine—CYP2D6—breast cancer	1.81e-05	0.0081	CrCbGaD
Bromodiphenhydramine—Tamoxifen—CYP2D6—breast cancer	1.76e-05	0.00788	CrCbGaD
Bromodiphenhydramine—Doxepin—CYP2D6—breast cancer	1.76e-05	0.00786	CrCbGaD
Bromodiphenhydramine—Tamoxifen—CYP3A4—breast cancer	1.51e-05	0.00676	CrCbGaD
Bromodiphenhydramine—Doxepin—CYP3A4—breast cancer	1.51e-05	0.00674	CrCbGaD
Bromodiphenhydramine—Orphenadrine—CYP3A4—breast cancer	1.47e-05	0.00657	CrCbGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—breast cancer	1.43e-05	0.00159	CbGpPWpGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—PIK3CA—breast cancer	1.41e-05	0.00156	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—breast cancer	1.39e-05	0.00154	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GPER1—breast cancer	1.37e-05	0.00152	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC2A2—breast cancer	1.37e-05	0.00152	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CNR2—breast cancer	1.37e-05	0.00152	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—CYP2D6—breast cancer	1.37e-05	0.00611	CrCbGaD
Bromodiphenhydramine—Amitriptyline—CYP2D6—breast cancer	1.36e-05	0.00608	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PTGER1—breast cancer	1.35e-05	0.00149	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ABCG2—breast cancer	1.34e-05	0.00149	CbGpPWpGaD
Bromodiphenhydramine—Promazine—CYP3A4—breast cancer	1.34e-05	0.00599	CrCbGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—ALB—breast cancer	1.33e-05	0.00148	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—NMBR—breast cancer	1.32e-05	0.00146	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—breast cancer	1.32e-05	0.00146	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR4—breast cancer	1.32e-05	0.00146	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—WNT1—breast cancer	1.29e-05	0.00143	CbGpPWpGaD
Bromodiphenhydramine—Tamoxifen—ABCB1—breast cancer	1.26e-05	0.00563	CrCbGaD
Bromodiphenhydramine—Doxepin—ABCB1—breast cancer	1.25e-05	0.00561	CrCbGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PTGER1—breast cancer	1.23e-05	0.00136	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—RAF1—breast cancer	1.21e-05	0.00133	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCL27—breast cancer	1.2e-05	0.00133	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PDE2A—breast cancer	1.2e-05	0.00133	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCL3—breast cancer	1.2e-05	0.00133	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—TFRC—breast cancer	1.2e-05	0.00133	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—breast cancer	1.19e-05	0.00132	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—AGTR2—breast cancer	1.18e-05	0.0013	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CXCL2—breast cancer	1.18e-05	0.0013	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—CYP3A4—breast cancer	1.17e-05	0.00524	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—PTHLH—breast cancer	1.17e-05	0.00129	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—CYP3A4—breast cancer	1.16e-05	0.00521	CrCbGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—AKT1—breast cancer	1.15e-05	0.00128	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—NCOA2—breast cancer	1.15e-05	0.00128	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—EDNRB—breast cancer	1.13e-05	0.00125	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—WNT10B—breast cancer	1.12e-05	0.00124	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.1e-05	0.00122	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCL27—breast cancer	1.09e-05	0.00121	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCL3—breast cancer	1.09e-05	0.00121	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PDE2A—breast cancer	1.09e-05	0.00121	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.06e-05	0.00118	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—ALB—breast cancer	1.03e-05	0.00114	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CALCA—breast cancer	1.03e-05	0.00114	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—ALB—breast cancer	1.02e-05	0.00455	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CXCL12—breast cancer	1e-05	0.00111	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CXCR4—breast cancer	1e-05	0.00111	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—ABCB1—breast cancer	9.76e-06	0.00437	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—NCOA1—breast cancer	9.72e-06	0.00107	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—ABCB1—breast cancer	9.7e-06	0.00434	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	9.47e-06	0.00105	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—AGTR1—breast cancer	9.07e-06	0.001	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—RGS2—breast cancer	8.79e-06	0.000973	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	8.74e-06	0.000967	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCL20—breast cancer	8.69e-06	0.000962	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—LGR6—breast cancer	8.51e-06	0.000942	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCDC88C—breast cancer	8.51e-06	0.000942	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—LPAR1—breast cancer	8.42e-06	0.000931	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	8.39e-06	0.000928	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SFRP1—breast cancer	8.12e-06	0.000898	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GPER1—breast cancer	8.12e-06	0.000898	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—RGS2—breast cancer	7.98e-06	0.000883	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PDE4D—breast cancer	7.95e-06	0.00088	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCL20—breast cancer	7.9e-06	0.000873	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—breast cancer	7.85e-06	0.000869	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NMBR—breast cancer	7.79e-06	0.000861	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CNR2—breast cancer	7.75e-06	0.000857	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—LPAR1—breast cancer	7.65e-06	0.000846	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PTGER1—breast cancer	7.24e-06	0.000801	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CUL5—breast cancer	7.24e-06	0.000801	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HEYL—breast cancer	7.24e-06	0.000801	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PDE4D—breast cancer	7.22e-06	0.000799	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CNR2—breast cancer	7.04e-06	0.000778	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RSPO3—breast cancer	6.8e-06	0.000753	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCL2—breast cancer	6.66e-06	0.000737	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AGTR2—breast cancer	6.66e-06	0.000737	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—WNT10B—breast cancer	6.62e-06	0.000732	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—WWOX—breast cancer	6.62e-06	0.000732	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—WNT1—breast cancer	6.62e-06	0.000732	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PTHLH—breast cancer	6.59e-06	0.000729	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—INHBB—breast cancer	6.45e-06	0.000714	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PDE2A—breast cancer	6.45e-06	0.000714	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCL27—breast cancer	6.45e-06	0.000714	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCL3—breast cancer	6.45e-06	0.000714	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—EDNRB—breast cancer	6.38e-06	0.000706	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—BMPR2—breast cancer	6.15e-06	0.000681	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DLL4—breast cancer	6.15e-06	0.000681	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCL2—breast cancer	6.05e-06	0.000669	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AGTR2—breast cancer	6.05e-06	0.000669	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PTHLH—breast cancer	5.98e-06	0.000662	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CDH5—breast cancer	5.9e-06	0.000653	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CALCA—breast cancer	5.8e-06	0.000642	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—EDNRB—breast cancer	5.79e-06	0.000641	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SFRP2—breast cancer	5.79e-06	0.00064	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PRLR—breast cancer	5.68e-06	0.000628	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCR4—breast cancer	5.67e-06	0.000627	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCL12—breast cancer	5.67e-06	0.000627	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—breast cancer	5.66e-06	0.000626	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GLI2—breast cancer	5.49e-06	0.000607	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—VCP—breast cancer	5.49e-06	0.000607	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	5.46e-06	0.000604	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—LEPR—breast cancer	5.4e-06	0.000597	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—breast cancer	5.39e-06	0.000596	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CALCA—breast cancer	5.27e-06	0.000583	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	5.25e-06	0.00058	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—PIK3CA—breast cancer	5.23e-06	0.000578	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCR4—breast cancer	5.15e-06	0.000569	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCL12—breast cancer	5.15e-06	0.000569	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AGTR1—breast cancer	5.12e-06	0.000567	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—breast cancer	5.09e-06	0.000563	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ARHGDIA—breast cancer	5.02e-06	0.000555	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FST—breast cancer	4.89e-06	0.000541	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HEY2—breast cancer	4.83e-06	0.000534	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RPS6KB2—breast cancer	4.77e-06	0.000528	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	4.74e-06	0.000525	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RGS2—breast cancer	4.72e-06	0.000522	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	4.67e-06	0.000517	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCL20—breast cancer	4.66e-06	0.000516	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AGTR1—breast cancer	4.65e-06	0.000515	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ITPR1—breast cancer	4.6e-06	0.000509	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—LPAR1—breast cancer	4.52e-06	0.0005	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TLE3—breast cancer	4.52e-06	0.0005	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HEY1—breast cancer	4.47e-06	0.000495	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DLL1—breast cancer	4.39e-06	0.000485	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	4.32e-06	0.000478	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HIST1H2BC—breast cancer	4.3e-06	0.000476	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HIST1H2BK—breast cancer	4.3e-06	0.000476	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GRB7—breast cancer	4.27e-06	0.000472	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PDE4D—breast cancer	4.27e-06	0.000472	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CSF2—breast cancer	4.25e-06	0.00047	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TAB2—breast cancer	4.19e-06	0.000464	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ITPR1—breast cancer	4.18e-06	0.000462	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CNR2—breast cancer	4.16e-06	0.00046	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CXCL8—breast cancer	4.15e-06	0.00046	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—MMP3—breast cancer	4.15e-06	0.000459	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	4.14e-06	0.000458	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DKK1—breast cancer	4.06e-06	0.000449	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—VEGFC—breast cancer	4.03e-06	0.000445	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—JAG2—breast cancer	3.97e-06	0.000439	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—WNT1—breast cancer	3.91e-06	0.000432	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PLA2G4A—breast cancer	3.9e-06	0.000431	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CSF2—breast cancer	3.86e-06	0.000427	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NOTCH4—breast cancer	3.71e-06	0.00041	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GZMB—breast cancer	3.68e-06	0.000407	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCL2—breast cancer	3.57e-06	0.000395	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AGTR2—breast cancer	3.57e-06	0.000395	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—BMP2—breast cancer	3.53e-06	0.000391	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PTHLH—breast cancer	3.53e-06	0.000391	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—EDNRB—breast cancer	3.42e-06	0.000379	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PGR—breast cancer	3.39e-06	0.000375	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—THBS1—breast cancer	3.37e-06	0.000373	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FLT1—breast cancer	3.22e-06	0.000356	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SQSTM1—breast cancer	3.2e-06	0.000354	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FGF3—breast cancer	3.2e-06	0.000354	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PIK3CG—breast cancer	3.19e-06	0.000353	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—JAG1—breast cancer	3.16e-06	0.00035	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NOTCH3—breast cancer	3.15e-06	0.000349	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PARP1—breast cancer	3.15e-06	0.000349	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CALCA—breast cancer	3.11e-06	0.000344	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RPS6—breast cancer	3.07e-06	0.00034	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FGF4—breast cancer	3.05e-06	0.000338	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCR4—breast cancer	3.04e-06	0.000336	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCL12—breast cancer	3.04e-06	0.000336	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PAK1—breast cancer	2.98e-06	0.00033	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TCF7L2—breast cancer	2.93e-06	0.000324	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AKT2—breast cancer	2.92e-06	0.000323	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PIK3CG—breast cancer	2.9e-06	0.00032	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HSP90AA1—breast cancer	2.83e-06	0.000313	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NOTCH2—breast cancer	2.83e-06	0.000313	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PIK3CD—breast cancer	2.8e-06	0.00031	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AGTR1—breast cancer	2.75e-06	0.000304	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PRL—breast cancer	2.75e-06	0.000304	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADAM10—breast cancer	2.71e-06	0.0003	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—STK11—breast cancer	2.71e-06	0.0003	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PLG—breast cancer	2.68e-06	0.000296	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AKT2—breast cancer	2.65e-06	0.000293	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FGF10—breast cancer	2.64e-06	0.000292	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PIK3CD—breast cancer	2.55e-06	0.000282	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PDGFA—breast cancer	2.54e-06	0.000281	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TGFBR2—breast cancer	2.51e-06	0.000277	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ITPR1—breast cancer	2.47e-06	0.000273	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—STAT5A—breast cancer	2.45e-06	0.000271	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MMP3—breast cancer	2.45e-06	0.000271	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ERBB4—breast cancer	2.45e-06	0.000271	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PIK3CB—breast cancer	2.44e-06	0.00027	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SMAD4—breast cancer	2.37e-06	0.000262	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IGF1R—breast cancer	2.36e-06	0.000261	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCL8—breast cancer	2.35e-06	0.00026	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HES1—breast cancer	2.32e-06	0.000256	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NCOR1—breast cancer	2.3e-06	0.000255	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PLA2G4A—breast cancer	2.3e-06	0.000255	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CSF2—breast cancer	2.28e-06	0.000252	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FGF1—breast cancer	2.28e-06	0.000252	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—RAF1—breast cancer	2.27e-06	0.000251	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NRG1—breast cancer	2.26e-06	0.00025	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—H2AFX—breast cancer	2.24e-06	0.000248	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—IL2—breast cancer	2.24e-06	0.000248	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—E2F1—breast cancer	2.23e-06	0.000247	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PIK3CB—breast cancer	2.22e-06	0.000245	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SPP1—breast cancer	2.14e-06	0.000237	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCL8—breast cancer	2.13e-06	0.000236	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ERBB3—breast cancer	2.12e-06	0.000234	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FGFR2—breast cancer	2.11e-06	0.000234	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—IL2—breast cancer	2.04e-06	0.000225	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TERT—breast cancer	2.03e-06	0.000225	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FGFR1—breast cancer	1.97e-06	0.000218	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HIF1A—breast cancer	1.94e-06	0.000215	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—LEP—breast cancer	1.9e-06	0.00021	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CAV1—breast cancer	1.88e-06	0.000208	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—KDR—breast cancer	1.86e-06	0.000205	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ESR1—breast cancer	1.81e-06	0.0002	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FN1—breast cancer	1.79e-06	0.000198	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NFKBIA—breast cancer	1.77e-06	0.000195	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NOTCH1—breast cancer	1.75e-06	0.000193	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—APC—breast cancer	1.71e-06	0.000189	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—KIT—breast cancer	1.71e-06	0.000189	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PIK3CG—breast cancer	1.71e-06	0.000189	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—EGF—breast cancer	1.69e-06	0.000187	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—MAPK3—breast cancer	1.64e-06	0.000181	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—BRAF—breast cancer	1.61e-06	0.000178	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IGF1—breast cancer	1.57e-06	0.000173	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AKT2—breast cancer	1.56e-06	0.000173	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—EGFR—breast cancer	1.56e-06	0.000172	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PIK3CD—breast cancer	1.5e-06	0.000166	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	1.49e-06	0.000165	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SERPINE1—breast cancer	1.49e-06	0.000165	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—KRAS—breast cancer	1.47e-06	0.000163	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NOS3—breast cancer	1.42e-06	0.000157	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	1.35e-06	0.00015	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MDM2—breast cancer	1.35e-06	0.000149	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RAF1—breast cancer	1.34e-06	0.000148	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RELA—breast cancer	1.34e-06	0.000148	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ERBB2—breast cancer	1.33e-06	0.000147	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PIK3CB—breast cancer	1.31e-06	0.000145	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MTOR—breast cancer	1.31e-06	0.000145	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCL8—breast cancer	1.26e-06	0.000139	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HRAS—breast cancer	1.25e-06	0.000138	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CDKN1B—breast cancer	1.23e-06	0.000136	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AKT1—breast cancer	1.22e-06	0.000135	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CASP3—breast cancer	1.21e-06	0.000133	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IL2—breast cancer	1.2e-06	0.000133	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—IL6—breast cancer	1.2e-06	0.000132	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCND1—breast cancer	1.17e-06	0.00013	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—JUN—breast cancer	1.17e-06	0.00013	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CTNNB1—breast cancer	1.16e-06	0.000129	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MMP9—breast cancer	1.14e-06	0.000126	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CDKN1A—breast cancer	1.14e-06	0.000126	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PTEN—breast cancer	1.13e-06	0.000125	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MAPK8—breast cancer	1.11e-06	0.000123	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AKT1—breast cancer	1.1e-06	0.000122	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SRC—breast cancer	1.05e-06	0.000116	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—VEGFA—breast cancer	1.02e-06	0.000113	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—STAT3—breast cancer	1.01e-06	0.000112	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MAPK3—breast cancer	9.68e-07	0.000107	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MYC—breast cancer	9.41e-07	0.000104	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TGFB1—breast cancer	9.39e-07	0.000104	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—EGFR—breast cancer	9.21e-07	0.000102	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—KRAS—breast cancer	8.7e-07	9.62e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PIK3CA—breast cancer	7.99e-07	8.84e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TP53—breast cancer	7.73e-07	8.55e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HRAS—breast cancer	7.39e-07	8.18e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IL6—breast cancer	7.07e-07	7.83e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AKT1—breast cancer	6.53e-07	7.22e-05	CbGpPWpGaD
